Search research articles
Contact Us
Filters
Showing results (21-30 of 31) with videos related to
Page
of 4
Sort By:
Oncogene
|
June 1, 1994
Substrate specificities and identification of a putative binding site for PI3K in the carboxy tail of the murine Flt3 receptor tyrosine kinase
R Rottapel, C W Turck, N Casteran, et al.
The EMBO Journal
|
February 18, 1999
Socs1 binds to multiple signalling proteins and suppresses steel factor-dependent proliferation
P De Sepulveda, K Okkenhaug, J L Rose, et al.
Blood
|
February 15, 1992
The c-kit receptor ligand functions as a mast cell chemoattractant
C J Meininger, H Yano, R Rottapel, et al.
Oncogene
|
April 1, 1993
Biochemical characterization and analysis of the transforming potential of the FLT3/FLK2 receptor tyrosine kinase
N Maroc, R Rottapel, O Rosnet, et al.
Differentiation; Research in Biological Diversity
|
June 1, 1995
Expression of Flt3 tyrosine kinase receptor gene in mouse hematopoietic and nervous tissues
O deLapeyrière, P Naquet, J Planche, et al.
Molecular and Cellular Biology
|
June 1, 1991
The Steel/W transduction pathway: kit autophosphorylation and its association with a unique subset of cytoplasmic signaling proteins is induced by the Steel factor
R Rottapel, M Reedijk, D E Williams, et al.
Oncogene
|
May 1, 1993
The FLT4 gene encodes a transmembrane tyrosine kinase related to the vascular endothelial growth factor receptor
F Galland, A Karamysheva, M J Pebusque, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 8, 1997
The SH3 domain of Itk/Emt binds to proline-rich sequences in the cytoplasmic domain of the T cell costimulatory receptor CD28
L E Marengère, K Okkenhaug, A Clavreul, et al.
The Journal of Biological Chemistry
|
May 31, 1996
Interaction with the phosphotyrosine binding domain/phosphotyrosine interacting domain of SHC is required for the transforming activity of the FLT4/VEGFR3 receptor tyrosine kinase
E Fournier, O Rosnet, S Marchetto, et al.
Nature Immunology
|
March 29, 2001
A point mutation in CD28 distinguishes proliferative signals from survival signals
K Okkenhaug, L Wu, K M Garza, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 31) with videos related to
Sort By:
Page
of 4
Oncogene
|
June 1, 1994
Substrate specificities and identification of a putative binding site for PI3K in the carboxy tail of the murine Flt3 receptor tyrosine kinase
R Rottapel, C W Turck, N Casteran, et al.
The EMBO Journal
|
February 18, 1999
Socs1 binds to multiple signalling proteins and suppresses steel factor-dependent proliferation
P De Sepulveda, K Okkenhaug, J L Rose, et al.
Blood
|
February 15, 1992
The c-kit receptor ligand functions as a mast cell chemoattractant
C J Meininger, H Yano, R Rottapel, et al.
Oncogene
|
April 1, 1993
Biochemical characterization and analysis of the transforming potential of the FLT3/FLK2 receptor tyrosine kinase
N Maroc, R Rottapel, O Rosnet, et al.
Differentiation; Research in Biological Diversity
|
June 1, 1995
Expression of Flt3 tyrosine kinase receptor gene in mouse hematopoietic and nervous tissues
O deLapeyrière, P Naquet, J Planche, et al.
Molecular and Cellular Biology
|
June 1, 1991
The Steel/W transduction pathway: kit autophosphorylation and its association with a unique subset of cytoplasmic signaling proteins is induced by the Steel factor
R Rottapel, M Reedijk, D E Williams, et al.
Oncogene
|
May 1, 1993
The FLT4 gene encodes a transmembrane tyrosine kinase related to the vascular endothelial growth factor receptor
F Galland, A Karamysheva, M J Pebusque, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 8, 1997
The SH3 domain of Itk/Emt binds to proline-rich sequences in the cytoplasmic domain of the T cell costimulatory receptor CD28
L E Marengère, K Okkenhaug, A Clavreul, et al.
The Journal of Biological Chemistry
|
May 31, 1996
Interaction with the phosphotyrosine binding domain/phosphotyrosine interacting domain of SHC is required for the transforming activity of the FLT4/VEGFR3 receptor tyrosine kinase
E Fournier, O Rosnet, S Marchetto, et al.
Nature Immunology
|
March 29, 2001
A point mutation in CD28 distinguishes proliferative signals from survival signals
K Okkenhaug, L Wu, K M Garza, et al.
Page
of 4